Uses of Florbetapir PET Scans Set to Take Shape


Neurologists are beginning to get their feet wet prescribing the recently approved PET beta-amyloid imaging agent florbetapir (Amyvid), which is now under consideration for Medicare coverage. In this video, our reporter Michele Sullivan takes you through the process of an Amyvid PET scan, which can help rule out Alzheimer’s disease as a cause of cognitive decline.

Next Article: